1
|
Maleb A, Sebbar E, Frikh M, Boubker S, Moussaoui A, El Mekkaoui A, Khannoussi W, Kharrasse G, Belefquih B, Lemnouer A, Ismaili Z, Elouennass M. [Saccharomyces cerevisiae invasive infection: The first reported case in Morocco]. J Mycol Med 2017; 27:266-270. [PMID: 28188052 DOI: 10.1016/j.mycmed.2017.01.008] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2016] [Revised: 11/21/2016] [Accepted: 01/06/2017] [Indexed: 10/20/2022]
Abstract
Saccharomyces cerevisiae is a cosmopolitan yeast, widely used in agro-alimentary and pharmaceutical industry. Its impact in human pathology is rare, but maybe still underestimated compared to the real situation. This yeast is currently considered as an emerging and opportunistic pathogen. Risk factors are immunosuppression and intravascular device carrying. Fungemias are the most frequent clinical forms. We report the first case of S. cerevisiae invasive infection described in Morocco, and to propose a review of the literature cases of S. cerevisiae infections described worldwide. A 77-year-old patient, with no notable medical history, who was hospitalized for a upper gastrointestinal stenosis secondary to impassable metastatic gastric tumor. Its history was marked by the onset of septic shock, with S. cerevisiae in his urine and in his blood, with arguments for confirmation of invasion: the presence of several risk factors in the patient, positive direct microbiological examination, abundant and exclusive culture of S. cerevisiae from clinical samples. Species identification was confirmed by the study of biochemical characteristics of the isolated yeast. Confirmation of S. cerevisiae infection requires a clinical suspicion in patients with risk factors, but also a correct microbiological diagnosis.
Collapse
Affiliation(s)
- A Maleb
- Laboratoire de microbiologie, centre hospitalier universitaire Mohammed VI d'Oujda, BP 4806, 60049 Oujda, Maroc; Faculté de médecine et de pharmacie, université Mohammed Premier d'Oujda, Oujda, Maroc
| | - E Sebbar
- Laboratoire de microbiologie, centre hospitalier universitaire Mohammed VI d'Oujda, BP 4806, 60049 Oujda, Maroc; Faculté de médecine et de pharmacie, université Mohammed Premier d'Oujda, Oujda, Maroc.
| | - M Frikh
- Service de bactériologie, hôpital militaire d'instruction Mohammed V de Rabat, Oujda, Maroc; Faculté de médecine et de pharmacie, université Mohammed V de Rabat, Oujda, Maroc
| | - S Boubker
- Faculté de médecine et de pharmacie, université Mohammed Premier d'Oujda, Oujda, Maroc; Service d'hépato-gastro-entérologie, centre hospitalier universitaire Mohammed VI d'Oujda, Oujda, Maroc
| | - A Moussaoui
- Faculté de médecine et de pharmacie, université Mohammed Premier d'Oujda, Oujda, Maroc; Service d'hépato-gastro-entérologie, centre hospitalier universitaire Mohammed VI d'Oujda, Oujda, Maroc
| | - A El Mekkaoui
- Faculté de médecine et de pharmacie, université Mohammed Premier d'Oujda, Oujda, Maroc; Service d'hépato-gastro-entérologie, centre hospitalier universitaire Mohammed VI d'Oujda, Oujda, Maroc
| | - W Khannoussi
- Faculté de médecine et de pharmacie, université Mohammed Premier d'Oujda, Oujda, Maroc; Service d'hépato-gastro-entérologie, centre hospitalier universitaire Mohammed VI d'Oujda, Oujda, Maroc
| | - G Kharrasse
- Faculté de médecine et de pharmacie, université Mohammed Premier d'Oujda, Oujda, Maroc; Service d'hépato-gastro-entérologie, centre hospitalier universitaire Mohammed VI d'Oujda, Oujda, Maroc
| | - B Belefquih
- Service de bactériologie, hôpital militaire d'instruction Mohammed V de Rabat, Oujda, Maroc; Faculté de médecine et de pharmacie, université Mohammed V de Rabat, Oujda, Maroc
| | - A Lemnouer
- Service de bactériologie, hôpital militaire d'instruction Mohammed V de Rabat, Oujda, Maroc; Faculté de médecine et de pharmacie, université Mohammed V de Rabat, Oujda, Maroc
| | - Z Ismaili
- Faculté de médecine et de pharmacie, université Mohammed Premier d'Oujda, Oujda, Maroc; Service d'hépato-gastro-entérologie, centre hospitalier universitaire Mohammed VI d'Oujda, Oujda, Maroc
| | - M Elouennass
- Service de bactériologie, hôpital militaire d'instruction Mohammed V de Rabat, Oujda, Maroc; Faculté de médecine et de pharmacie, université Mohammed V de Rabat, Oujda, Maroc
| |
Collapse
|
2
|
Endosomal and AP-3-dependent vacuolar trafficking routes make additive contributions to Candida albicans hyphal growth and pathogenesis. EUKARYOTIC CELL 2010; 9:1755-65. [PMID: 20870878 DOI: 10.1128/ec.00029-10] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Candida albicans mutants deficient in vacuolar biogenesis are defective in polarized hyphal growth and virulence. However, the specific vacuolar trafficking routes required for hyphal growth and virulence are unknown. In Saccharomyces cerevisiae, two trafficking routes deliver material from the Golgi apparatus to the vacuole. One occurs via the late endosome and is dependent upon Vps21p, while the second bypasses the endosome and requires the AP-3 complex, including Aps3p. To determine the significance of these pathways in C. albicans hyphal growth and virulence, aps3Δ/Δ, vps21Δ/Δ, and aps3Δ/Δ vps21Δ/Δ mutant strains were constructed. Analysis of vacuolar morphology and localization of the vacuolar protein Mlt1p suggests that C. albicans Aps3p and Vps21p mediate two distinct transport pathways. The vps21Δ/Δ mutant has a minor reduction in hyphal elongation, while the aps3Δ/Δ mutant has no defect in hyphal growth. Interestingly, the aps3Δ/Δ vps21Δ/Δ double mutant has dramatically reduced hyphal growth. Overexpression of the Ume6p transcriptional activator resulted in constitutive hyphal growth of wild-type, aps3Δ/Δ, and vps21Δ/Δ strains and formation of highly vacuolated subapical compartments. Thus, Ume6p-dependent transcriptional responses are sufficient to induce subapical vacuolation. However, the aps3Δ/Δ vps21Δ/Δ mutant formed mainly pseudohyphae that lacked vacuolated compartments. The aps3Δ/Δ strain was virulent in a mouse model of disseminated infection; the vps21Δ/Δ mutant failed to kill mice but persisted within kidney tissue, while the double mutant was avirulent and cleared from the kidneys. These results suggest that while the AP-3 pathway alone has little impact on hyphal growth or virulence, it is much more significant when endosomal trafficking is disrupted.
Collapse
|